Cargando…

Depression following ChAdOx1-S/nCoV-19 vaccine

Detalles Bibliográficos
Autor principal:	Uvais, N.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asociación Universitaria de Zaragoza para el Progreso de la Psiquiatría y la Salud Mental. Published by Elsevier España, S.L.U. 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482696/ https://www.ncbi.nlm.nih.gov/pubmed/34608345 http://dx.doi.org/10.1016/j.ejpsy.2021.08.001

Ejemplares similares

Myelin-Oligodendrocyte Glycoprotein Antibody-Positive Longitudinally Extensive Transverse Myelitis following ChAdOx1-S/nCoV-19 Vaccine
por: Mappila Veettil, Jabir Sayed, et al.
Publicado: (2022)

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination
por: Garibashvili, Tamara, et al.
Publicado: (2022)

Thromboses of major arteries and ChAdOx1 nCov-19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Rapidly Progressive Dementia with Asymmetric Rigidity Following ChAdOx1 nCoV-19 Vaccination
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2022)

Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2
por: Anupama, Y.J., et al.
Publicado: (2021)

Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2022)

Acute Arterial Occlusion Following ChAdOx1 nCov-19 (Oxford–AstraZeneca) Vaccination
por: Ali, Azhar, et al.
Publicado: (2022)

Accelerated Hypertension and Intracerebral Haemorrhage Following First Dose of ChAdOx1-nCOV-19 Vaccination
por: Pandey, Shweta, et al.
Publicado: (2022)

Myocardial Infarction after ChAdOx1 nCoV-19 in a Young Male
por: Sagar, V. V. S. S., et al.
Publicado: (2022)

Venous sinus thrombosis following vaccination with ChAdOx1 nCov-19()
por: Morales Varas, G., et al.
Publicado: (2022)

Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine
por: Clayton-Chubb, Daniel, et al.
Publicado: (2021)

Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine
por: Saraceno, Janaína Jamile Ferreira, et al.
Publicado: (2021)

Successful treatment of thromboses of major arteries after ChAdOx1 nCov-19 vaccination
por: Goereci, Yasemin, et al.
Publicado: (2021)

ChAdOx1 nCov-19 vaccine-induced thrombotic thrombocytopenic purpura successfully treated with plasmapheresis
por: Wang, Yen-Ching, et al.
Publicado: (2021)

Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdOx1 nCov-19 vaccine
por: Scavone, Mariangela, et al.
Publicado: (2021)

Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccine
por: Ahmer, Sadaf, et al.
Publicado: (2022)

Effectiveness of ChAdOx1 nCOV-19 Vaccine: Experience of a tertiary care institute
por: Koshy, George
Publicado: (2022)

ChAdOx1 nCoV-19 effectiveness during an unprecedented surge in SARS COV-2 infections
por: Satwik, Ruma, et al.
Publicado: (2021)

BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes
por: Abdul-Jawad, Sultan, et al.
Publicado: (2022)

Breakthrough infections and waning immune responses with ChAdOx1 nCoV‐19 or mRNA vaccine in healthcare workers
por: Lim, So Yun, et al.
Publicado: (2022)

Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination
por: Spataro, Rossella, et al.
Publicado: (2022)

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
por: Schultz, Nina H., et al.
Publicado: (2021)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Lodge, Archie
Publicado: (2020)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Chauhan, Anil, et al.
Publicado: (2020)

Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies
por: Uaprasert, Noppacharn, et al.
Publicado: (2021)

Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine
por: Shahrigharahkoshan, Shaghayegh, et al.
Publicado: (2021)

Longitudinally extensive transverse myelitis following ChAdOx1 nCoV-19 vaccine
por: Shetty, AJ, et al.
Publicado: (2022)

A Rare Case of Superior Ophthalmic Vein Thrombosis and Thrombocytopenia Following ChAdOx1 nCoV-19 Vaccine Against SARS-CoV-2
por: Panovska-Stavridis, Irina, et al.
Publicado: (2021)

Serious adverse events following immunization after ChAdOx1 nCov-19 vaccination in India: a single center experience
por: Maurya, Miteshkumar Rajaram, et al.
Publicado: (2021)

Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine
por: Rogawski McQuade, Elizabeth T, et al.
Publicado: (2021)

Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
por: Normark, Johan, et al.
Publicado: (2021)

Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination
por: Crane, Phillip, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura after ChAdOx1 nCoV-19 vaccine
por: Lee, Hui Ping, et al.
Publicado: (2021)

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
por: Ogbe, Ane, et al.
Publicado: (2022)

Post ChAdOx1 nCoV-19 vaccination frontal lobe syndrome
por: Tapdia, Madhusudan, et al.
Publicado: (2022)

Autonomic dysfunction post-inoculation with ChAdOx1 nCoV-19 vaccine
por: Karimi Galougahi, Keyvan
Publicado: (2021)

Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignancies
por: Thookhamme, Chayapa, et al.
Publicado: (2023)

Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia()
por: Huang, Ching-Tai, et al.
Publicado: (2021)

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
por: Greinacher, Andreas, et al.
Publicado: (2021)

New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine
por: Aladdin, Yasser, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_01dna1nlsns4hfleqc93tpon6s